Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy™
  • Oncology
    • Overview
    • ImmunePrep™
    • ChemoPrep™
    • ChemoPure™
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Email Alerts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 12, 2025 8:03am EDT

Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making

Mar 05, 2025 7:53am EST

Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses

Feb 25, 2025 7:54am EST

Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst

Feb 18, 2025 7:47am EST

Sigyn Therapeutics to Present at Tomorrow’s Emerging Growth Conference

Feb 05, 2025 8:35am EST

Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference

Jan 29, 2025 7:53am EST

Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors

May 15, 2024 12:13pm EDT

Sigyn Therapeutics Reports First Quarter 2024 Financial Results

May 07, 2024 7:45am EDT

Sigyn Therapeutics™ Discloses Publication of “Sigyn TherapyTM, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections.”

Mar 05, 2024 9:00am EST

Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference

Feb 21, 2024 8:45am EST

Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap